| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.13.12.1814 |
| P698 | PubMed publication ID | 8241102 |
| P2093 | author name string | H Li | |
| N Maeda | |||
| R L Reddick | |||
| P433 | issue | 12 | |
| P304 | page(s) | 1814-1821 | |
| P577 | publication date | 1993-12-01 | |
| P1433 | published in | Arteriosclerosis and thrombosis : a journal of vascular biology | Q27709770 |
| P1476 | title | Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice | |
| P478 | volume | 13 |
| Q77926970 | A direct role for the macrophage low density lipoprotein receptor in atherosclerotic lesion formation |
| Q24646308 | A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism |
| Q28365792 | Abnormal lipoprotein metabolism and reversible female infertility in HDL receptor (SR-BI)-deficient mice |
| Q35098335 | ApoA-I deficiency in mice is associated with redistribution of apoA-II and aggravated AApoAII amyloidosis |
| Q64056930 | ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice |
| Q28504715 | ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis |
| Q43986679 | Apolipoprotein A-I is necessary for the in vivo formation of high density lipoprotein competent for scavenger receptor BI-mediated cholesteryl ester-selective uptake |
| Q28829054 | Apolipoprotein AI deficiency inhibits serum opacity factor activity against plasma high density lipoprotein via a stabilization mechanism |
| Q44031811 | Apolipoprotein CI deficiency markedly augments plasma lipoprotein changes mediated by human cholesteryl ester transfer protein (CETP) in CETP transgenic/ApoCI-knocked out mice. |
| Q33746638 | Apolipoprotein E and atherosclerosis: insight from animal and human studies |
| Q73835678 | Apolipoprotein-mediated cellular cholesterol/phospholipid efflux and plasma high density lipoprotein level in mice |
| Q36455892 | Apolipoproteins AI and B as therapeutic targets |
| Q39028912 | Applications and Limitations of Mouse Models for Understanding Human Atherosclerosis |
| Q28212769 | Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime |
| Q34905815 | Comparison of high-density lipoprotein cholesterol to apolipoprotein A-I and A-II to predict coronary calcium and the effect of insulin resistance |
| Q57038754 | Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis |
| Q28587419 | Delayed loss of cholesterol from a localized lipoprotein depot in apolipoprotein A-I-deficient mice |
| Q41546267 | Development of apolipoprotein E-deficient mice |
| Q34035387 | Dietary squalene increases high density lipoprotein-cholesterol and paraoxonase 1 and decreases oxidative stress in mice |
| Q34558799 | Dynamics of reverse cholesterol transport: protection against atherosclerosis |
| Q71858718 | Exogenous supply of artificial lipoproteins does not decrease susceptibility to atherosclerosis in cholesterol-fed rabbits |
| Q34204885 | Gene targeting approaches to complex genetic diseases: atherosclerosis and essential hypertension |
| Q34107177 | Gene therapy for dyslipidemia: clinical prospects |
| Q24792755 | Gene therapy for lipid disorders |
| Q30444546 | Genetic control of high density lipoprotein-cholesterol in AcB/BcA recombinant congenic strains of mice |
| Q35062386 | HDL in risk prediction and its direct and indirect involvement in atherogenesis |
| Q45158054 | Hepatic and Aortic Arch Expression and Serum Levels of Syndecan-1 in ApoE-/- Mice |
| Q35152178 | High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions |
| Q34990624 | High-density lipoproteins and atherosclerosis |
| Q36951483 | Hypercholesterolemia and reduced HDL-C promote hematopoietic stem cell proliferation and monocytosis: studies in mice and FH children |
| Q44174326 | Increased risk of atherosclerosis by elevated plasma levels of phospholipid transfer protein |
| Q35791953 | Induction of fatal inflammation in LDL receptor and ApoA-I double-knockout mice fed dietary fat and cholesterol. |
| Q40409394 | Knockouts. Targeting the mouse genome: a compendium of knockouts (Part I) |
| Q77452740 | Lipoproteins and atherogenesis |
| Q35203793 | Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment |
| Q37614469 | Modulation of adipose tissue lipolysis and body weight by high-density lipoproteins in mice |
| Q36037988 | Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease |
| Q34040090 | Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia |
| Q35043691 | Mouse models as tools for dissecting disorders of lipoprotein metabolism |
| Q38293457 | Mouse models of disturbed HDL metabolism |
| Q42252844 | Nascent very-low-density lipoprotein triacylglycerol hydrolysis by lipoprotein lipase is inhibited by apolipoprotein E in a dose-dependent manner |
| Q40966240 | New insights into atherosclerosis from studies with mouse models |
| Q41902903 | Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT. |
| Q33601946 | Progesterone receptor-induced gene expression in primary mouse granulosa cell cultures |
| Q37365875 | Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV. |
| Q35212558 | Regulation of reverse cholesterol transport and clinical implications |
| Q73680652 | Single repeat deletion in ApoA-I blocks cholesterol esterification and results in rapid catabolism of delta6 and wild-type ApoA-I in transgenic mice |
| Q33993233 | The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis? |
| Q28510638 | The acute phase response in apolipoprotein A-1 knockout mice: apolipoprotein serum amyloid A and lipid distribution in plasma high density lipoproteins |
| Q73872471 | The apolipoprotein A-I/C-III/A-IV gene cluster: ApoC-III and ApoA-IV expression is regulated by two common enhancers |
| Q53750486 | The low down on lipoprotein lipase |
| Q33922270 | The protective role of high-density lipoproteins in atherosclerosis |
| Q24629974 | The response-to-retention hypothesis of early atherogenesis |
| Q36467350 | Trans-Golgi proteins participate in the control of lipid droplet and chylomicron formation |
| Q34294723 | Transcription factors as drug targets: opportunities for therapeutic selectivity. |
| Q57502636 | What do we know about apolipoprotein E and the prevention of cardiovascular disease? |
Search more.